Skip to main content
Top
Published in: Diabetologia 7/2004

01-07-2004 | Short Communication

Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans

Authors: C. Thamer, M. Haap, O. Bachmann, T. zur Nieden, O. Tschritter, N. Stefan, A. Fritsche, S. Jacob, M. Stumvoll, H. Häring

Published in: Diabetologia | Issue 7/2004

Login to get access

Abstract

Aims/hypothesis

Fat-rich diets can acutely induce insulin resistance. Data from adiponectin knock-out mice suggest that this effect might be increased in the absence of adiponectin. In the present study we tested whether plasma adiponectin concentrations influence changes in insulin sensitivity induced by a short-term dietary intervention in humans.

Methods

We analysed data from 27 healthy, non-obese men with normal glucose tolerance. These men ate a diet high in fat and a diet high in carbohydrates for three days each.

Results

The high-fat diet induced a significant drop in insulin sensitivity (determined by euglycaemic–hyperinsulinaemic clamp) compared to baseline (0.100±0.009 vs 0.083±0.007 µmol·kg−1·min−1·(pmol·l−1), p=0.01). The drop in insulin sensitivity was more pronounced in subjects with low serum adiponectin (0.094±0.011 vs 0.077±0.010 µmol·kg−1·min−1·(pmol·l−1), p=0.02) than in subjects with high serum adiponectin (0.103±0.011 vs 0.090±0.040 µmol·kg−1·min−1·(pmol·l−1), p=0.16). In the whole group the high-carbohydrate, low-fat diet did not cause an increase in insulin sensitivity (0.095±0.007 vs 0.102±0.009 µmol·kg−1·min−1·(pmol·l−1), p=0.06). However, insulin sensitivity was significantly increased in the subgroup with low serum adiponectin levels (0.084±0.013 vs 0.099±0.018 µmol·kg−1·min−1·(pmol·l−1), p=0.01). In an additional multivariate analysis post-intervention insulin sensitivity was predicted by pre-intervention insulin sensitivity (p<0.001) and adiponectin concentrations (p=0.001).

Conclusions/interpretation

These data indicate that the reduction in insulin sensitivity achieved by a short-term high-fat diet is more pronounced in non-obese subjects with low serum adiponectin. Thus it is possible that the restriction of dietary fat and a diet high in carbohydrates might be particularly effective in subjects with low adiponectin such as obese or Type 2 diabetic individuals.
Literature
1.
go back to reference Weyer C, Funahashi T, Tanaka S et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRefPubMed Weyer C, Funahashi T, Tanaka S et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRefPubMed
2.
go back to reference Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946CrossRefPubMed Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946CrossRefPubMed
3.
go back to reference Tschritter O, Fritsche A, Thamer C et al. (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239–243CrossRefPubMed Tschritter O, Fritsche A, Thamer C et al. (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239–243CrossRefPubMed
4.
go back to reference Yamauchi T, Kamon J, Minokoshi Y et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295CrossRefPubMed Yamauchi T, Kamon J, Minokoshi Y et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295CrossRefPubMed
5.
go back to reference Bachmann OP, Dahl DB, Brechtel K et al. (2001) Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50:2579–2584CrossRefPubMed Bachmann OP, Dahl DB, Brechtel K et al. (2001) Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50:2579–2584CrossRefPubMed
6.
go back to reference Thamer C, Machann J, Tschritter O et al. (2002) Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 34:646–649CrossRefPubMed Thamer C, Machann J, Tschritter O et al. (2002) Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 34:646–649CrossRefPubMed
7.
go back to reference Maeda N, Shimomura I, Kishida K et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed Maeda N, Shimomura I, Kishida K et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed
8.
go back to reference Lindsay RS, Funahashi T, Hanson RL et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57–58CrossRefPubMed Lindsay RS, Funahashi T, Hanson RL et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57–58CrossRefPubMed
Metadata
Title
Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans
Authors
C. Thamer
M. Haap
O. Bachmann
T. zur Nieden
O. Tschritter
N. Stefan
A. Fritsche
S. Jacob
M. Stumvoll
H. Häring
Publication date
01-07-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1430-7

Other articles of this Issue 7/2004

Diabetologia 7/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.